![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
GW Pharm. | LSE:GWP | London | Ordinary Share | GB0030544687 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 735.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMGWP
RNS Number : 2568Y
GW Pharmaceuticals PLC
13 May 2016
GW Pharmaceuticals PLC Director/PDMR Shareholding
13 May 2016
GW Pharmaceuticals PLC ("GW Pharmaceuticals" or the "Company")
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
Cambridge, UK, 13 May 2016: GW Pharmaceuticals (AIM: GWP, NASDAQ:GWPH) hereby provides notification that the Company was notified on 12 May 2016 of the following series of transactions in the Ordinary 0.1 pence shares of GW Pharmaceuticals PLC.
On 12 May 2016 Dr Geoffrey Guy, a Director of the Company, gifted 200,000 ordinary shares to each of two close family members. Each gift represents less than 0.1% of shares in issue. The gifts took place when the market price was 437 pence per share. As one of these family members is a minor, 200,000 of the gifted shares continue to be included within the calculation of Dr Guy's total beneficial interest.
These transfers follow the sale, by the minor family member, of 300,000 Ordinary shares, representing 0.11% of shares in issue. This sale of these shares completed on 11 May 2016, achieving an average price of 444 pence per Ordinary share.
Following these transactions Dr Guy's total retained beneficial interest in the Ordinary 0.1 pence shares of GW Pharmaceuticals plc is 13,797,852 shares equating to 5.25% of shares in issue.
For further information, please contact:
GW Pharmaceuticals PLC +44 (0)1980 557 000
Adam George, Company Secretary
Peel Hunt LLP (Nominated Adviser)
James Steel/Oliver Jackson +44 (0) 20 7418 8900
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHLLFSSETIVLIR
(END) Dow Jones Newswires
May 13, 2016 10:50 ET (14:50 GMT)
1 Year Gw Pharmaceuticals Chart |
1 Month Gw Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions